Anabolic Androgenic Steroid use in the Nordic Countries: A Reply to Bilgrei and Sand⊘y

Bilgrei O. R. , & Sand⊘y T. A. (2015). Should the use of anabolic-androgenic steroids be considered a major public health problem in the Nordic countries? A commentary on Sagoe et al. (2015). Nordic Studies on Alcohol and Drugs, 32(1), 25–26.

Cunningham R. L. , Lumia A. R. , & McGinnis M. Y. (2013). Androgenic anabolic steroid exposure during adolescence: Ramifications for brain development and behavior. Hormones and Behavior, 64, 350–356.

Hildebrandt T. , Langenbucher J. W. , Flores A. , Harty S. , & Berlin H. (2014). The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men. Psychology of Addictive Behaviors, 28, 1096–1104.

Jenssen I. H. , & Johannessen K. B. (2015). Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway. Body Image, 12, 6–13.

Kanayama G. , Hudson J. I. , & Pope, H. G. Jr. (2009a). Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug and Alcohol Dependence, 102, 130–137.

Kicman A. T. , & Gower D. B. (2003). Anabolic steroids in sport: Biochemical, clinical and analytical perspectives. Annals of Clinical Biochemistry, 40, 321–356.

Klötz F. , Garle M. , Granath F. , & Thiblin I. (2006). Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Archives of General Psychiatry, 63, 1274–1279.

Klötz F. , Petersson A. , Isacson D. , & Thiblin I. (2007). Violent crime and substance abuse: A medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Science International, 173, 57–63.

Landry G. L. , & Primos, W. A. Jr. (1990). Anabolic steroid abuse. Advances in Pediatrics, 37, 185–205.

Lundholm L. , Frisell T. , Lichtenstein P. , & Långström N. (2014). Anabolic androgenic steroids and violent offending: Confounding by polysubstance abuse among 10,365 general population men. Addiction, doi: 10.1111/add.12715

Pagonis T. A. , Angelopoulos N. V. , Koukoulis G. N. , & Hadjichristodoulou C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562.

Pope, H. G. Jr. & Kanayama G. (2012). Anabolic-androgenic steroids. In Verster J. , Brady K. , Galanter M. , & Conrod P. (Eds.), Drug abuse and addiction in medical illness: Causes, consequences and treatment (pp. 251–264). New York: Springer.

Pope, H. G. Jr. Kanayama G. , Athey A. , Ryan E. , Hudson J. I. , & Baggish A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. American Journal on Addictions, 23, 371–377.

Pope, H. G. Jr. Kouri E. M. , & Hudson J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57, 133–140.

Sagoe D. , Andreassen C. S. , & Pallesen S. (2014). The aetiology and trajectory of anabolic-androgenic steroid use initiation: A systematic review and synthesis of qualitative research. Substance Abuse Treatment, Prevention, and Policy, 9, 27 doi: 10.1186/1747-597X-9-27

Sagoe D. , Torsheim T. , Molde H. , Andreassen C. S. , & Pallesen S. (2015a). Anabolic-androgenic steroid use in the Nordic countries: A meta-analysis and meta-regression analysis. Nordic Studies on Alcohol and Drugs, 32(1), 7–20.

Sagoe D. , Huang K. , Molde H. , Andreassen C. S. , & Pallesen S. (2015b). Perceived anabolic-androgenic steroid use is associated with perceived neuroticism. Journal of Substance Use, doi: 10.3109/14659891.2015.1009510

Sand⊘y T. A. (2013). Anabole steroider i Norge. En oversikt fra befolkningsunders⊘kelser [Anabolic steroids in Norway. An overview of population studies]. Oslo: Statens Institutt for Rusmiddelforskning. Retrieved from http://www.sirus.no/filestore/Import_vedlegg/Vedlegg_publikasjon/sirusrap.4.13.pdf